A citation-based method for searching scientific literature

Ilah Shin, Yae Won Park, Sung Soo Ahn, Seok-Gu Kang, Jong Hee Chang, Se Hoon Kim, Seung-Koo Lee. J Neuroradiol 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Epigenetic cancer evolution, one cell at a time.
Carolina N Perdigoto. Nat Rev Genet 2019
4
100

Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.
Priscilla K Brastianos, Peleg M Horowitz, Sandro Santagata, Robert T Jones, Aaron McKenna, Gad Getz, Keith L Ligon, Emanuele Palescandolo, Paul Van Hummelen, Matthew D Ducar,[...]. Nat Genet 2013
336
100

Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L.
Rong Rong, Xiaoling Tang, David H Gutmann, Keqiang Ye. Proc Natl Acad Sci U S A 2004
96
100

Meningiomas and neurofibromatosis.
Stéphane Goutagny, Michel Kalamarides. J Neurooncol 2010
63
100

TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas.
Annamaria Biczok, Theo Kraus, Bogdana Suchorska, Nicole A Terpolilli, Jun Thorsteinsdottir, Armin Giese, Joerg C Tonn, Christian Schichor. J Neurooncol 2018
26
100

Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas.
Dimitri Barski, Marietta Wolter, Guido Reifenberger, Markus J Riemenschneider. Brain Pathol 2010
53
100

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015.
Quinn T Ostrom, Haley Gittleman, Gabrielle Truitt, Alexander Boscia, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2018
744
100

The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.
Winward Choy, Won Kim, Daniel Nagasawa, Stephanie Stramotas, Andrew Yew, Quinton Gopen, Andrew T Parsa, Isaac Yang. Neurosurg Focus 2011
111
100

Meningioma: A Review of Epidemiology, Pathology, Diagnosis, Treatment, and Future Directions.
Christian Ogasawara, Brandon D Philbrick, D Cory Adamson. Biomedicines 2021
1
100

Emerging Medical Treatments for Meningioma in the Molecular Era.
Fares Nigim, Hiroaki Wakimoto, Ekkehard M Kasper, Linda Ackermans, Yasin Temel. Biomedicines 2018
13
100

A review of epigenetic and gene expression alterations associated with intracranial meningiomas.
Shuhan He, Martin H Pham, Matthew Pease, Gabriel Zada, Steven L Giannotta, Kai Wang, William J Mack. Neurosurg Focus 2013
36
100

Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.
Victoria E Clark, E Zeynep Erson-Omay, Akdes Serin, Jun Yin, Justin Cotney, Koray Ozduman, Timuçin Avşar, Jie Li, Phillip B Murray, Octavian Henegariu,[...]. Science 2013
425
100



DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q.
M Josefa Bello, Cinthia Amiñoso, Isabel Lopez-Marin, Dolores Arjona, Pilar Gonzalez-Gomez, M Eva Alonso, Jesus Lomas, Jose M de Campos, M Elena Kusak, Jesus Vaquero,[...]. Acta Neuropathol 2004
50
100

An overview of meningiomas.
Robin A Buerki, Craig M Horbinski, Timothy Kruser, Peleg M Horowitz, Charles David James, Rimas V Lukas. Future Oncol 2018
71
100

Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas.
Victoria E Clark, Akdes Serin Harmancı, Hanwen Bai, Mark W Youngblood, Tong Ihn Lee, Jacob F Baranoski, A Gulhan Ercan-Sencicek, Brian J Abraham, Abraham S Weintraub, Denes Hnisz,[...]. Nat Genet 2016
130
100

Epigenetics in cancer.
Manel Esteller. N Engl J Med 2008
100

Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes.
Chang-Shi Chen, Shu-Chuan Weng, Ping-Hui Tseng, Ho-Pi Lin, Ching-Shih Chen. J Biol Chem 2005
194
100

AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.
Matthew L Bush, Janet Oblinger, Victoria Brendel, Griffin Santarelli, Jie Huang, Elena M Akhmametyeva, Sarah S Burns, Justin Wheeler, Jeremy Davis, Charles W Yates,[...]. Neuro Oncol 2011
40
100


The HDAC Inhibitor LAQ824 Enhances Epigenetic Reprogramming and In Vitro Development of Porcine SCNT Embryos.
Jun-Xue Jin, Sanghoon Lee, Anukul Taweechaipaisankul, Geon A Kim, Byeong Chun Lee. Cell Physiol Biochem 2017
18
100

Impaired survival and long-term neurological problems in benign meningioma.
Hanna van Alkemade, Michelle de Leau, Edith M T Dieleman, Jan W P F Kardaun, Rob van Os, W Peter Vandertop, Wouter R van Furth, Lukas J A Stalpers. Neuro Oncol 2012
124
100

Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings.
Ossama Al-Mefty, Paulo A S Kadri, Svetlana Pravdenkova, Jeffrey R Sawyer, Colin Stangeby, Muhammad Husain. J Neurosurg 2004
143
100

Analysis of CDKN2A gene alterations in recurrent and non-recurrent meningioma.
Anne Guyot, Mathilde Duchesne, Sandrine Robert, Anne-Sophie Lia, Paco Derouault, Erwan Scaon, Leslie Lemnos, Henri Salle, Karine Durand, François Labrousse. J Neurooncol 2019
11
100

Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains.
Benjamin P Berman, Daniel J Weisenberger, Joseph F Aman, Toshinori Hinoue, Zachary Ramjan, Yaping Liu, Houtan Noushmehr, Christopher P E Lange, Cornelis M van Dijk, Rob A E M Tollenaar,[...]. Nat Genet 2011
404
100

Histological classification and molecular genetics of meningiomas.
Markus J Riemenschneider, Arie Perry, Guido Reifenberger. Lancet Neurol 2006
310
100

Molecular Profiling of 22 Primary Atypical Meningiomas Shows the Prognostic Significance of 18q Heterozygous Loss and CDKN2A/B Homozygous Deletion on Recurrence-Free Survival.
Valeria Barresi, Michele Simbolo, Adele Fioravanzo, Maria Liliana Piredda, Maria Caffo, Claudio Ghimenton, Giampietro Pinna, Michele Longhi, Antonio Nicolato, Aldo Scarpa. Cancers (Basel) 2021
2
100


Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase.
S J Darkin-Rattray, A M Gurnett, R W Myers, P M Dulski, T M Crumley, J J Allocco, C Cannova, P T Meinke, S L Colletti, M A Bednarek,[...]. Proc Natl Acad Sci U S A 1996
419
100

Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.
Leland Rogers, Igor Barani, Marc Chamberlain, Thomas J Kaley, Michael McDermott, Jeffrey Raizer, David Schiff, Damien C Weber, Patrick Y Wen, Michael A Vogelbaum. J Neurosurg 2015
240
100

Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.
Manish K Aghi, Bob S Carter, Garth R Cosgrove, Robert G Ojemann, Sepideh Amin-Hanjani, Robert L Martuza, William T Curry, Fred G Barker. Neurosurgery 2009
281
100

Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Primary and Recurrent Meningioma.
Huiyuan Zhang, Lin Qi, Yuchen Du, L Frank Huang, Frank K Braun, Mari Kogiso, Yanling Zhao, Can Li, Holly Lindsay, Sibo Zhao,[...]. Cancers (Basel) 2020
4
100

Decellularized porcine brain matrix for cell culture and tissue engineering scaffolds.
Jessica A DeQuach, Shauna H Yuan, Lawrence S B Goldstein, Karen L Christman. Tissue Eng Part A 2011
117
100

Advances in meningioma genetics: novel therapeutic opportunities.
Matthias Preusser, Priscilla K Brastianos, Christian Mawrin. Nat Rev Neurol 2018
53
100

Histone deacetylase inhibitor AR-42 differentially affects cell-cycle transit in meningeal and meningioma cells, potently inhibiting NF2-deficient meningioma growth.
Sarah S Burns, Elena M Akhmametyeva, Janet L Oblinger, Matthew L Bush, Jie Huang, Volker Senner, Ching-Shih Chen, Abraham Jacob, D Bradley Welling, Long-Sheng Chang. Cancer Res 2013
28
100

Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas.
Tareq A Juratli, Christian Thiede, Mara V A Koerner, Shilpa S Tummala, Dirk Daubner, Ganesh M Shankar, Erik A Williams, Maria Martinez-Lage, Silke Soucek, Katja Robel,[...]. Oncotarget 2017
51
100

Role of Merlin/NF2 inactivation in tumor biology.
A M Petrilli, C Fernández-Valle. Oncogene 2016
149
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.